AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Heidelberg Pharma AG

Director's Dealing Jul 24, 2025

201_dirs_2025-07-24_6613cf0a-2ad1-4fba-9708-3f13db4eb2b5.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 24 July 2025 14:24

Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, Acquisition of 90,000 shares through the exercise of 90,000 stock options under the 2011 stock option program (tranche 2; issue 2016) for employees and members of the Management Board of Heidelberg Pharma AG.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

24.07.2025 / 14:23 CET/CEST

The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title: Prof. Dr.
First name: Andreas
Last name(s): Pahl

2. Reason for the notification

a) Position / status

Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Heidelberg Pharma AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: DE000A11QVV0

b) Nature of the transaction

Acquisition of 90,000 shares through the exercise of 90,000 stock options under the 2011 stock option program (tranche 2; issue 2016) for employees and members of the Management Board of Heidelberg Pharma AG.
Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)

Price(s) Volume(s)
1.89 EUR 170,100.00 EUR

d) Aggregated information

Price Aggregated volume
1.8900 EUR 170,100.0000 EUR

e) Date of the transaction

23/07/2025; UTC+2

f) Place of the transaction

Outside a trading venue


24.07.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com
End of News EQS News Service

99844  24.07.2025 CET/CEST

Talk to a Data Expert

Have a question? We'll get back to you promptly.